MICHAEL MUSGROVE: Open Payments
NPI 1033166368 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,458 in 247 payments from 20 companies in 2025. Trend: 2023 $3,407 · 2024 $3,842 · 2025 $4,458
Food & beverage: $4,458
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $555 |
| Otsuka America Pharmaceutical, Inc. | 25 | $527 |
| Neurocrine BioSciences, Inc. | 16 | $396 |
| Lundbeck LLC | 19 | $384 |
| ABBVIE INC. | 19 | $340 |
| Alkermes, Inc. | 20 | $312 |
| Vanda Pharmaceuticals Inc. | 19 | $287 |
| Axsome Therapeutics, Inc. | 18 | $264 |
| Corium, LLC | 9 | $212 |
| Janssen Pharmaceuticals, Inc | 9 | $200 |
Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, FANAPT, ARISTADA, Azstarys, Auvelity.
Industry payments across TX — which companies pay providers there.
